SCHEMBL28676502

SCHEMBL28676502

O=C(O)N1CCN2Cc3cc(OCCN4CCCCC4)c(-c4c(O)cccc4Cl)c(F)c3OC[C@H]2C1

nearest known ligand 0.68

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
KRAS P01116 17/20 0.68
HTR2A P28223 1/20 0.38
HTR2C P28335 1/20 0.38
HTR2B P41595 1/20 0.38
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30483793 0.92 KRAS (0.80) KRAS
SCHEMBL24558337 0.92 KRAS (0.80) KRAS
SCHEMBL29693152 0.90 KRAS (0.65) KRASHTR2AHTR2CHTR2B
SCHEMBL24558249 0.90 KRAS (0.65) KRASHTR2AHTR2CHTR2B
SCHEMBL28654630 0.85 KRAS (0.84) KRAS
SCHEMBL28650748 0.85 KRAS (0.63) KRAS
SCHEMBL26883204 0.84 KRAS (0.55) KRASHTR2AHTR2CHTR2BTSHR
SCHEMBL31107225 0.84 KRAS (0.55) KRASHTR2AHTR2CHTR2BTSHR
SCHEMBL28669292 0.84 KRAS (0.82) KRAS
SCHEMBL28671358 0.84 KRAS (0.63) KRAS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113508118-A Fused tricyclic compounds useful as anticancer agents 阿斯利康(瑞典)有限公司 2021-10-15 CN disclosed